BRIEF published on 08/13/2025 at 18:05, 1 year ago Procédure de redressement judiciaire chez CARMAT : mise à jour Offre De Reprise Redressement Judiciaire CARMAT Aeson® Suspension Boursière
PRESS RELEASE published on 08/13/2025 at 18:00, 1 year ago Informations privilégiées / Autres communiqués CARMAT suspend son cours de bourse en amont de l'audience du 19 août 2025 pour examen de l'offre de reprise en plan de cession dans le cadre de la procédure de redressement judiciaire Bourse AUDIENCE Suspension Redressement Judiciaire CARMAT
BRIEF published on 08/01/2025 at 14:05, 1 year 1 month ago CARMAT : Reprise de Cotation et Point sur le Redressement Judiciaire Offre De Reprise Redressement Judiciaire Reprise De Cotation CARMAT Aeson® Cœur Artificiel
BRIEF published on 08/01/2025 at 14:05, 1 year 1 month ago CARMAT: Resumption of Quotation and Update on Judicial Recovery Takeover Offer CARMAT Resumption Of Quotation Judicial Recovery Aeson® Artificial Heart
PRESS RELEASE published on 08/01/2025 at 14:00, 1 year 1 month ago Informations privilégiées / Autres communiqués CARMAT fait un point sur la procédure de redressement judiciaire en cours et annonce la reprise de cotation de l'action à partir du 4 août 2025 Offre De Reprise Redressement Judiciaire Reprise De Cotation CARMAT Procédure
BRIEF published on 07/01/2025 at 20:50, 1 year 2 months ago Bilan semestriel du contrat de liquidité de CARMAT Contrat De Liquidité Actions Redressement Judiciaire CARMAT Société De Bourse
BRIEF published on 07/01/2025 at 20:50, 1 year 2 months ago Half-yearly report on CARMAT's liquidity contract Liquidity Contract Actions CARMAT Judicial Recovery Stockbroker
PRESS RELEASE published on 07/01/2025 at 20:45, 1 year 2 months ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité Communiqué sur le bilan semestriel du contrat de liquidité de CARMAT avec Gilbert Dupont. Détails des actions et espèces en juin 2025 Contrat De Liquidité Actions Liquidité Gilbert Dupont CARMAT
BRIEF published on 06/20/2025 at 19:15, 1 year 2 months ago CARMAT launches a donation campaign in the face of a financial crisis Funding Heart Failure Artificial Heart Financial Crisis Donation Campaign
BRIEF published on 06/20/2025 at 19:15, 1 year 2 months ago CARMAT lance une campagne de dons face à une crise financière Financement Coeur Artificiel Insuffisance Cardiaque Crise Financière Campagne De Dons
Published on 09/12/2026 at 02:35, 11 hours 32 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 7 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 2 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 42 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 7 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 36 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 51 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 56 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 22 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 51 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
